Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Surgical Oncology |
| Vol/bind | 37 |
| Udgave nummer | 1 |
| Sider (fra-til) | 72-79 |
| Antal sider | 8 |
| ISSN | 0748-7983 |
| DOI | |
| Status | Udgivet - 1 jan. 2011 |
ID: 33792447